Early image acquisition 68Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma
Authors:
- 16 July 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (2) , 748-752
Abstract
Purpose To overcome difficulties with regard to anatomic discrimination of intrapelvic tumors and non-specific intrapelvic uptake (i.e. excreted activity in the urinary bladder) by early acquisition of FAPI-PET in prone position. Methods 15 patients with rectosigmoid (RSC) and squamous cell carcinoma of the anus (SCCA) underwent early-imaging 68Ga-FAPI-46-PET/CT-scans in prone position 5.9 ± 1.3 min after radiotracer injection. SUV and metric values for primary tumors, metastases, bladder and background tissues were measured. Tumor-to-background ratios (TBR) were calculated. Results Despite early acquisition, SUV was already high in tumors and metastases, leading to high TBR. A sufficient, on average at least 2.56 ± 0.66 cm, spatial distance between tumor and bladder uptake was observed in all cases. Conclusion An early-imaging protocol in prone position with 68Ga-FAPI-46-PET/CT presents a viable option for non-invasive staging of SCCA and RSC with high TBR and good spatial separation from the urinary bladder.Keywords
This publication has 12 references indexed in Scilit:
- Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: A systematic review and meta-analysisEuropean Journal of Radiology, 2024
- First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical CancerClinical Nuclear Medicine, 2023
- Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Comparison of [68 Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT in colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Cancer-associated fibroblasts in colorectal cancerClinical and Translational Oncology, 2021
- Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory StudyJournal of Nuclear Medicine, 2021
- Equivalent tumor detection for early and late FAPI-46 PET acquisitionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- The role of fibroblast activation protein in health and malignancyCancer and Metastasis Reviews, 2020
- The Role of68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical ExperienceJournal of Nuclear Medicine, 2020